Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Ovarian”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03207412
What this trial is testing

Human Amniotic Epithelial Cells Treatment for Ovarian Insufficiency

Who this might be right for
Premature Ovarian Failure
The Second Affiliated Hospital of Chongqing Medical University 20
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Not applicableEnded earlyNCT06068738
What this trial is testing

Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Exscientia AI Limited 13
Early research (Phase 1)Study completedNCT02324439
What this trial is testing

Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Southern Illinois University 15
Early research (Phase 1)Study completedNCT01219777
What this trial is testing

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Ritu Salani 9
Testing effectiveness (Phase 2)Study completedNCT00097019
What this trial is testing

Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed

Who this might be right for
Ovarian Cancer
Genentech, Inc. 53
Testing effectiveness (Phase 2)Study completedNCT00003892
What this trial is testing

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
NCIC Clinical Trials Group 22
Early research (Phase 1)Study completedNCT00616941
What this trial is testing

Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Ludwig Institute for Cancer Research 28
Testing effectiveness (Phase 2)Ended earlyNCT04780945
What this trial is testing

Functional Analysis of BRCAness

Who this might be right for
Ovarian Neoplasm EpithelialHomologous Recombination DeficiencyBRCA1 Mutation+1 more
Leiden University Medical Center 27
Not applicableStudy completedNCT05368207
What this trial is testing

Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient

Who this might be right for
Small Cell Carcinoma, Hypercalcaemic TypeOvarian Cancer
University Health Network, Toronto 1
Not applicableUnknownNCT05099978
What this trial is testing

Asian Multicenter Prospective Study of ctDNA Sequencing

Who this might be right for
Cervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma+3 more
National Cancer Center, Japan 506
Testing effectiveness (Phase 2)Study completedNCT00635193
What this trial is testing

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Who this might be right for
Ovarian Cancer, Primary Peritoneal Cancer
AbbVie (prior sponsor, Abbott) 138
Not applicableUnknownNCT04369352
What this trial is testing

Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria

Who this might be right for
Recurrent Ovarian Carcinoma
Medical University Innsbruck 150
Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Not applicableStudy completedNCT02952521
What this trial is testing

Ovarian Tumor Biopsies to Study Response to Treatments

Who this might be right for
Epithelial Ovarian Cancer
University Health Network, Toronto 5
Testing effectiveness (Phase 2)Study completedNCT00543049
What this trial is testing

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Who this might be right for
Platinum Refractory Epithelial Ovarian CancerPrimary Cancer of the PeritoneumCancer of the Fallopian Tube
AGO Study Group 73
Early research (Phase 1)WithdrawnNCT03607955
What this trial is testing

Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Washington University School of Medicine
Large-scale testing (Phase 3)UnknownNCT04055038
What this trial is testing

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

Who this might be right for
Ovarian CancerOvarian NeoplasmsSerous Adenocarcinoma+3 more
Blokhin's Russian Cancer Research Center 164
Testing effectiveness (Phase 2)Study completedNCT01666444
What this trial is testing

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Celgene 297
Next Page